Onk Therapeutics
Onk Therapeutics's email is info@onktherapeutics.com
.
ONK Therapeutics is an innovative cell therapy company dedicated to developing the next generation of off-the-shelf, optimally engineered natural killer (NK) cell therapies targeting both hematological malignancies and solid tumors.
View Top Employees for Onk Therapeutics
Website | onktherapeutics.com | |
Industry | Biotechnology | |
Location | Galway, Galway, Ireland | |
Employees | 7 | |
Founded | 2015 |
HQ | Unit 1 an Coirneal Pier Road | |
info@onktherapeutics.com | ||
Funding | 21,500,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | onktherapeutics.com | |
Industry | Biotechnology | |
Location | Galway, Galway, Ireland | |
Employees | 7 | |
Founded | 2015 | |
linkedin.com/company/onk-therapeutics | ||
HQ | Unit 1 an Coirneal Pier Road | |
info@onktherapeutics.com | ||
Funding | 21,500,000 USD |
Top Competitors for Onk Therapeutics
Onk Therapeutics Questions
Where are Onk Therapeutics's headquarters?
Onk Therapeutics's headquarters are in Unit 1 an Coirneal Pier Road
What is Onk Therapeutics's official website?
Onk Therapeutics's website is onktherapeutics.com
How many employees are working in Onk Therapeutics right now?
Onk Therapeutics has
7 employees.
View the Email and Phone Numbers for all 7 working at Onk Therapeutics.
What is Onk Therapeutics's industry?
Onk Therapeutics's industry is
Biotechnology
Who are Onk Therapeutics's top competitors?
Onk Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Onk Therapeutics's email address?
Onk Therapeutics's email address is info@onktherapeutics.com
What are Onk Therapeutics's categories?
Onk Therapeutics's categories are Health Care, Therapeutics
What is Onk Therapeutics's location?
Onk Therapeutics's location is
Galway, Galway, Ireland
When was Onk Therapeutics's founded?
Onk Therapeutics's founding year is 2015
What is Onk Therapeutics's funding?
Onk Therapeutics's funding is 21,500,000 USD
What is Onk Therapeutics's current status?
Onk Therapeutics's current status is operating
Top Onk Therapeutics Employees
Chief Executive Officer
cnowers@genomichealth.com
+44771-752-4392
Head Of Research And Development And Site Head
duggal.rohit@att.net
+1858-481-2105
Chairman Of The Board
hugh.odowd@novartis.com
+1617-337-4701
Chief Executive Officer
cnowers@genomichealth.com
+44771-752-4392
Senior Scientist
Scientist
Research And Development Program Manager
dhardwi1@nd.edu